News
Fintel reports that on June 6, 2025, Goldman Sachs initiated coverage of Viatris (NasdaqGS:VTRS) with a Neutral recommendation. Analyst Price Forecast Suggests 26.78% Upside As of June 1, 2025, the ...
In a notable move in India’s flexible workspace sector, Oyo-owned Innov8 has raised fresh capital at a valuation of ₹1,000 ...
Stocks like Brigade Enterprises, TD Power Systems, JSW Infrastructure, Biocon, United Spirits, Can Fin Homes, Container ...
Nifty continues to oscillate within a well-defined consolidation band of 24,400–25,200 for the fifth consecutive week, ...
India’s benchmark indices tarded slightly higher on Wednesday, reflecting gains seen across other Asian markets amid signs of ...
Eli Lilly's weight-loss and diabetes drug Mounjaro, has seen sales in India jump 60 per cent between April and May. The country has the world’s third-highest number of obese people.
Goldman Sachs launches company-wide AI tool to boost productivity Marco Argenti, Goldman Sachs’ Chief Information Officer, called the launch a major milestone in the firm’s AI journey.
China 1 strategy gains momentum in pharma, but full monetisation still 2-3 years away: Goldman Sachs
Indian pharmaceutical and biotech sectors have started witnessing tangible benefits from the global shift away from China, as early signs of the China 1 strategy materialising emerge, according to a ...
Goldman Sachs on Monday announced a firmwide launch of an artificial intelligence assistant, a tool driven by generative AI, to boost productivity, according to an internal memo seen by Reuters.
This aligns with Goldman Sachs forecast of a 31% order inflow CAGR between FY25 and FY28, up sharply from their earlier estimate of 15.5%. The report added, “We forecast a 27% earnings CAGR for ...
Goldman Sachs said it sees no convincing relationship between the 10-year Treasury yield and annual S&P 500 returns in data going back to 1940. Finance 2025-06-03T09:00:01Z ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results